AT429813T - Encapsulation of sensitive liquid components into a matrix for recovery of discrete shelf-stable particles - Google Patents

Encapsulation of sensitive liquid components into a matrix for recovery of discrete shelf-stable particles

Info

Publication number
AT429813T
AT429813T AT99951433T AT99951433T AT429813T AT 429813 T AT429813 T AT 429813T AT 99951433 T AT99951433 T AT 99951433T AT 99951433 T AT99951433 T AT 99951433T AT 429813 T AT429813 T AT 429813T
Authority
AT
Austria
Prior art keywords
encapsulation
recovery
matrix
liquid components
sensitive liquid
Prior art date
Application number
AT99951433T
Other languages
German (de)
Inventor
Lengerich Bernhard Van
Original Assignee
Gen Mills Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10370098P priority Critical
Priority to US10969698P priority
Priority to US09/233,443 priority patent/US7201923B1/en
Application filed by Gen Mills Inc filed Critical Gen Mills Inc
Priority to PCT/US1999/020905 priority patent/WO2000021504A1/en
Publication of AT429813T publication Critical patent/AT429813T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72Encapsulation
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00Finished or partly finished bakery products
    • A21D13/20Partially or completely coated products
    • A21D13/28Partially or completely coated products characterised by the coating composition
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/117Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/135Individual or non-extruded flakes, granules or shapes having similar size, e.g. breakfast cereals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L9/00Puddings; Cream substitutes; Preparation or treatment thereof
    • A23L9/10Puddings; Dry powder puddings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • A23P10/25Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2220/00Biochemical treatment
    • A23C2220/20Treatment with microorganisms
    • A23C2220/204Use of bacteria which are encapsulated, entrapped or immobilised; Fermentation with these bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/38Medical treatment of vector-borne diseases characterised by the agent
    • Y02A50/381Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a virus
    • Y02A50/384Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a virus of the genus Flavivirus
    • Y02A50/387Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a virus of the genus Flavivirus the disease being Yellow fever, i.e. Ochropyra
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/46Medical treatment of waterborne diseases characterized by the agent
    • Y02A50/462The waterborne disease being caused by a virus
    • Y02A50/465The waterborne disease being caused by a virus the virus being the poliovirus, i.e. Poliomyelitis or Polio
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/46Medical treatment of waterborne diseases characterized by the agent
    • Y02A50/468The waterborne disease being caused by a bacteria
    • Y02A50/469The waterborne disease being caused by a bacteria the bacteria being clostridium botulinum, i.e. Botulism
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/46Medical treatment of waterborne diseases characterized by the agent
    • Y02A50/468The waterborne disease being caused by a bacteria
    • Y02A50/471The waterborne disease being caused by a bacteria the bacteria being Vibrio cholerae, i.e. Cholera
AT99951433T 1998-03-23 1999-10-06 Encapsulation of sensitive liquid components into a matrix for recovery of discrete shelf-stable particles AT429813T (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10370098P true 1998-10-09 1998-10-09
US10969698P true 1998-11-24 1998-11-24
US09/233,443 US7201923B1 (en) 1998-03-23 1999-01-20 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
PCT/US1999/020905 WO2000021504A1 (en) 1998-10-09 1999-10-06 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles

Publications (1)

Publication Number Publication Date
AT429813T true AT429813T (en) 2009-05-15

Family

ID=27379589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951433T AT429813T (en) 1998-03-23 1999-10-06 Encapsulation of sensitive liquid components into a matrix for recovery of discrete shelf-stable particles

Country Status (13)

Country Link
EP (1) EP1119345B1 (en)
JP (1) JP5408684B2 (en)
AR (1) AR020729A1 (en)
AT (1) AT429813T (en)
AU (1) AU777977B2 (en)
CA (1) CA2345815C (en)
CO (1) CO5150196A1 (en)
DE (1) DE69940821D1 (en)
DK (1) DK1119345T3 (en)
ES (1) ES2326502T3 (en)
PE (1) PE13212000A1 (en)
PT (1) PT1119345E (en)
WO (1) WO2000021504A1 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
AU9164601A (en) * 2000-10-02 2002-04-15 Novozymes As Particles containing active in visco-elastic liquids
US6617026B2 (en) 2000-10-02 2003-09-09 Novozymes A/S Particles containing active in visco-elastic liquids
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US7431986B2 (en) * 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
DE102004039196B4 (en) 2004-08-12 2008-07-31 Dr.Kamprad Kg New formulation of L-tryptophan
US7318920B2 (en) * 2004-09-27 2008-01-15 Ez-Med Company Low water activity nutritional product having beneficial microbial and high oil content
KR20070111490A (en) * 2005-01-18 2007-11-21 이뮤솔 인코퍼레이티드 Novel quinolinium salts and derivatives
AU2006257726B2 (en) * 2005-06-17 2010-09-09 Australian Nuclear Science And Technology Organisation Particles having hydrophobic material therein
WO2006133519A1 (en) 2005-06-17 2006-12-21 Australian Nuclear Science And Technology Organisation Particles comprising a releasable dopant therein
EP1906915B1 (en) * 2005-06-17 2017-09-27 Australian Nuclear Science And Technology Organisation Particles having hydrophobic material therein
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
DE602006020347D1 (en) * 2005-12-16 2011-04-07 Oxthera Inc Compositions and methods for oxalatreduktion
JP5869745B2 (en) 2006-02-03 2016-02-24 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー 25-treatment of vitamin d deficiency and deficiency by hydroxy vitamin d2 and 25-hydroxy vitamin d3
PL2679228T3 (en) 2006-06-21 2018-07-31 Opko Ireland Global Holdings, Ltd. Therapy using vitamin D repletion agent and vitamin D hormone replacement agent
US8703191B2 (en) 2006-07-25 2014-04-22 Intelgenx Corp. Controlled-release pharmaceutical tablets
JP5647516B2 (en) 2007-04-25 2014-12-24 シトクロマ インコーポレイテッド The methods and compounds for vitamin d Therapy
KR101691876B1 (en) 2007-04-25 2017-01-02 사이토크로마 인코포레이티드 Oral controlled release compositions comprising vitamin d compound and waxy carrier
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
EP2373693A4 (en) 2009-01-06 2012-04-25 Curelon Llc Compositions and methods for the treatment or the prevention oral infections by e. coli
ES2668909T3 (en) 2009-01-06 2018-05-23 Galenagen, Llc Compositions comprising protease, amylase and lipase for use in the treatment of Staphylococcus aureus infections
DE202009001095U1 (en) 2009-01-26 2010-03-11 Igv Institut Für Getreideverarbeitung Gmbh Encapsulated bioactive active ingredients in the matrix
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
CN102458138B (en) * 2009-06-05 2014-08-20 通用工厂公司 Encapsulated omega-3 fatty acids for baked goods production
AU2010268426B2 (en) * 2009-07-03 2015-01-22 Cargill, Incorporated A particulate flavor delivery system, a method of making it and use thereof
US20110086085A1 (en) * 2009-10-13 2011-04-14 Wenzel Scott W Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US8926308B2 (en) 2010-04-21 2015-01-06 Intercontinental Great Brands Llc Dough extruders and methods
WO2012017012A1 (en) 2010-08-05 2012-02-09 Basf Se Stabilizer
GB2503852B (en) 2011-04-21 2018-12-12 Curemark Llc Compounds for the treatment of neuropsychiatric disorders
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US9560877B2 (en) 2012-03-13 2017-02-07 General Mills, Inc. Cereal-based product with improved eating quality fortified with dietary fiber and/or calcium
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
CA2913971A1 (en) * 2013-05-31 2014-12-04 Universal Stabilization Technologies, Inc. Polymeric compositions containing ambient-temperature stable biopharmaceuticals & methods for formulation thereof
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
MX2017001751A (en) 2014-08-07 2017-05-30 Opko Ireland Global Holdings Ltd Adjunctive therapy with 25-hydroxyvitamin d.
WO2017108131A1 (en) * 2015-12-23 2017-06-29 Sonneveld Group B.V. Dough mixture comprising particles comprised of starch for the production of bakery products with an open crumb structure
JP5945087B1 (en) * 2016-03-16 2016-07-05 株式会社大貴 Method and apparatus for manufacturing a excreta treating material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191015312A (en) * 1910-06-25 1911-03-23 John Hutcheon Improved Process of Producing Cooked Foods Impregnated with certain Bacteria.
US3786123A (en) * 1971-01-25 1974-01-15 S Katzen Method for stabilizing and preserving nutrients and products
EP0202409A3 (en) * 1985-03-25 1989-02-01 Miles Inc. A process for the production of viable and stable dry microorganisms for food and agricultural purposes
US5314692A (en) 1987-08-24 1994-05-24 Cultor Ltd. Enzyme premix for feed and method
WO1990015537A1 (en) 1989-06-07 1990-12-27 Nabisco Brands, Inc. Extrusion baking of cookies having liposome encapsulated ingredients
US5079012A (en) * 1989-06-07 1992-01-07 Nabisco Brands, Inc. Shelf stable cookie product containing heat and shear sensitive additives and method of making
US5074902A (en) * 1990-07-30 1991-12-24 Connick Jr William J Granular products containing fungi encapsulated in a wheat gluten matrix for biological control of weeds
DE4041752A1 (en) 1990-12-24 1992-06-25 Henkel Kgaa Enzyme preparation for washing and cleaning products
US5508053A (en) * 1993-08-13 1996-04-16 Kraft Foods, Inc. Method for producing vegetable pasta
JP2002511777A (en) * 1996-10-28 2002-04-16 ゼネラル ミルズ,インコーポレイテッド Embedding and encapsulation regulating release particles
SK167899A3 (en) 1997-06-04 2000-09-12 Dsm Nv PROCESS FOR PREPARING AQUEOUS PHYTASE-CONTAINING LIQUIDS AND USEì (54) THEREOF
PE06012000A1 (en) 1998-03-23 2000-07-25 Gen Mills Inc Encapsulated components in food products

Also Published As

Publication number Publication date
EP1119345B1 (en) 2009-04-29
WO2000021504A8 (en) 2000-06-22
PT1119345E (en) 2009-07-27
AU6387299A (en) 2000-05-01
AU777977B2 (en) 2004-11-04
AR020729A1 (en) 2002-05-29
ES2326502T3 (en) 2009-10-13
JP5408684B2 (en) 2014-02-05
DK1119345T3 (en) 2009-08-03
CA2345815A1 (en) 2000-04-20
CA2345815C (en) 2011-02-08
WO2000021504A1 (en) 2000-04-20
PE13212000A1 (en) 2000-12-01
EP1119345A1 (en) 2001-08-01
JP2002527375A (en) 2002-08-27
DE69940821D1 (en) 2009-06-10
CO5150196A1 (en) 2002-04-29
EP1119345A4 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
DE69812919D1 (en) Brand with electronic chip
DE69522514T2 (en) A semiconductor device and manufacturing method
DE69734340D1 (en) nasal device
DE69732862D1 (en) A semiconductor device for recording of infrared images
DE69940005D1 (en) Printing system and method
DE69531177D1 (en) A card type semiconductor device
DE69840118D1 (en) RF IC package
IT1318131B1 (en) Method and device for the mutual monitoring of joined 'dicomando
DE69525795D1 (en) A semiconductor device and manufacturing method
DE69811295T2 (en) bike computer
DE69835794D1 (en) Semiconductor circuit and control method to
DE69904320D1 (en) On-chip circuitry and method for memory-circuit-test
NO20002039D0 (en) encapsulation
FR2723735B1 (en) Case has automatic connection for distribution of reagents in a device in particular a blood analyzer.
DE69912017D1 (en) Peripheral device and control method therefor
AT169143T (en) security label
DE69835106D1 (en) Embedded logic analyzer
DE69825251D1 (en) Polarizer and flüssikristallanzeigeelement
AT414471T (en) Device for Lipolysistherapy
DE694872T1 (en) Improved chip
FI971880A0 (en) The pharmaceutical composition and a method for easily fusible carrier for the preparation thereof
NO990989D0 (en) chocolate Particles
DE122010000011I1 (en) Liquid medicines gonadotropinhaltige
DE69532329D1 (en) Separation device and separation method
FI972736A0 (en) Foerbaettrad metod Foer cellbyte

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1119345

Country of ref document: EP